News

Absci Initiates IND-Enabling Studies for ABS-101, Aiming for Enhanced Anti-TL1A Antibody Therapy

Absci has embarked on IND-enabling studies for ABS-101, an anti-TL1A antibody, leveraging its generative AI technology to streamline the development …

Continue ›››

Ultima Genomics Launches UG 100™ Sequencer to Advance Affordable Genomic Sequencing

Ultima Genomics, Inc., a pioneer in genomic sequencing technology, has introduced the UG 100™, a groundbreaking sequencer designed to significantly …

Continue ›››

Exscientia Launches New Clinical Study to Enhance Cancer Treatment Through AI

Exscientia plc, a UK-based AI-driven precision medicine company, has initiated a clinical study, EXCYTE-2, focusing on acute myeloid leukaemia (AML) patients. …

Continue ›››

Aqemia Raises €60m in Series A Funding to Advance AI-Driven Drug Discovery

Aqemia, a Paris-based biotech startup, raised an additional €30 million in a Series A funding extension, totaling €60 million in …

Continue ›››

Monomer Bio Raises $5.6 Million to Advance Laboratory Automation in Drug Discovery

Based in San Francisco, Monomer Bio has secured $5.6 million in seed financing to develop its platform that combines laboratory …

Continue ›››

Neuralink Claims First Successful Human Brain Implant

Neuralink, the neurotechnology firm led by entrepreneur Elon Musk, has reportedly achieved a significant milestone by successfully implanting its first …

Continue ›››

Mayo Clinic's Stem Cell Research Takes to Space

A new mission aboard SpaceX CRS-29, launching from NASA's Kennedy Space Center in Cape Canaveral, Florida, on January 30, 2024, …

Continue ›››

This Collaboration Aims to Achieve Infinite Recyclability of Plastics

Basecamp has announced their expanded collaboration with Protein Evolution to help eliminate global polyurethane and polyamide waste, which account for a …

Continue ›››

In an Industry First, Veeva Migrates Study Portfolio of Top 20 Biopharmas to Vault EDC

Veeva Systems, a prominent player in cloud-based software for the global life sciences industry, has successfully migrated a significant portfolio …

Continue ›››

Innovative Approach to Combat Arthritis: Mesenbio's Stem Cell Therapy

Mesenbio, a pioneering biotechnology firm emerging from the University of York, has recently secured a significant £1.4 million investment. This …

Continue ›››

A Proof-of-Concept Study Towards Novel ALS Therapy

Verge Genomics, a clinical-stage biotechnology company, has just initiated a Phase 1b proof-of-concept study for VRG50635, a drug developed for …

Continue ›››

Xcell Biosciences and ElevateBio Forge Partnership to Enhance Cell and Gene Therapy Development

Xcell Biosciences, Inc., a notable company in the field of cell and gene therapy applications, has recently unveiled a strategic …

Continue ›››